BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Topics
»
Disease categories and therapies
» Neurology/psychiatric
Neurology/psychiatric
RSS
BioLineRx begins phase IIb BL-1020 trial in schizophrenia
June 16, 2008
Opexa reports positive 2-year data from phase I/II Tovaxin studies
June 13, 2008
Pain and King submit NDA for Remoxy for moderate to severe pain
June 13, 2008
Targacept and AstraZeneca evaluate AZD-3480 in phase II adult ADHD trial
June 13, 2008
Positive preclinical profile of Pfizer's novel nicotinic alpha7 agonist PHA-709829
June 12, 2008
Epix initiates second trial in phase IIb Alzheimer's disease program
June 12, 2008
First phase III study of AZ-004 for acute agitation completes enrollment
June 12, 2008
PMI-150 enters pivotal study in acute pain
June 12, 2008
Shire undertakes voluntary recall of a limited portion of Daytrana patches
June 11, 2008
AstraZeneca submits Seroquel XR in Europe for major depressive disorder
June 11, 2008
Previous
1
2
…
1742
1743
1744
1745
1746
1747
1748
1749
1750
…
3013
3014
Next